Stocks & Investing
Stocks and Investing
Stocks and Investing
Tue, July 18, 2017
[ Tue, Jul 18th 2017
] - WOPRAI
[ Tue, Jul 18th 2017
] - WOPRAI
[ Tue, Jul 18th 2017
] - WOPRAI
Mon, July 17, 2017
[ Mon, Jul 17th 2017
] - WOPRAI
[ Mon, Jul 17th 2017
] - WOPRAI
[ Mon, Jul 17th 2017
] - WOPRAI
[ Mon, Jul 17th 2017
] - WOPRAI
[ Mon, Jul 17th 2017
] - WOPRAI
[ Mon, Jul 17th 2017
] - WOPRAI
[ Mon, Jul 17th 2017
] - WOPRAI
[ Mon, Jul 17th 2017
] - WOPRAI
[ Mon, Jul 17th 2017
] - WOPRAI
[ Mon, Jul 17th 2017
] - WOPRAI
[ Mon, Jul 17th 2017
] - WOPRAI
[ Mon, Jul 17th 2017
] - WOPRAI
[ Mon, Jul 17th 2017
] - WOPRAI
[ Mon, Jul 17th 2017
] - WOPRAI
[ Mon, Jul 17th 2017
] - WOPRAI
[ Mon, Jul 17th 2017
] - WOPRAI
[ Mon, Jul 17th 2017
] - WOPRAI
[ Mon, Jul 17th 2017
] - WOPRAI
[ Mon, Jul 17th 2017
] - WOPRAI
David Lewis Maintained (ZBH) at Buy with Increased Target to $150 on, Jul 17th, 2017
David Lewis of Morgan Stanley, Maintained "Zimmer Biomet Holdings, Inc." (ZBH) at Buy with Increased Target from $137 to $150 on, Jul 17th, 2017.
David has made no other calls on ZBH in the last 4 months.
There are 4 other peers that have a rating on ZBH. Out of the 4 peers that are also analyzing ZBH, 2 agree with David's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Travis Steed of "Cantor Fitzgerald" Initiated at Hold and Held Target at $137 on, Friday, June 30th, 2017
- Larry Biegelsen of "Wells Fargo" Downgraded from Buy to Hold on, Friday, April 28th, 2017
These are the ratings of the 2 analyists that currently disagree with David
- Christopher Pasquale of "Guggenheim" Upgraded from Hold to Strong Buy on, Wednesday, July 12th, 2017
- Isaac Ro of "Goldman Sachs" Initiated at Strong Sell and Held Target at $92 on, Tuesday, May 16th, 2017
